<DOC>
	<DOC>NCT01734889</DOC>
	<brief_summary>The purpose of this study is to verify that pediatric patients, especially those who are not old enough to swallow capsules, accept the taste and palatability of a new suspension.</brief_summary>
	<brief_title>Taste and Palatability of Orfadin Suspension</brief_title>
	<detailed_description>This is an open, non-randomized, non-controlled, multiple-dose study in 18 pediatric patients. The treatment period is three days, and during the study the subjects will rate the taste and palatability of the suspension or (for younger children) their parents will rate the childÂ´s acceptance of the suspension. The study consists of a screening period, a 3 day treatment period and a 1 week follow-up period.</detailed_description>
	<mesh_term>Tyrosinemias</mesh_term>
	<mesh_term>Nitisinone</mesh_term>
	<criteria>Patients with HT1 currently managed on Orfadin (nitisinone) capsules. Age from 1 month to less than 18 years. Signed informed consent. Any medical condition which in the opinion of the investigator makes the subject unsuitable for inclusion. Enrollment in another concurrent clinical study, or intake of an investigational medicinal product (IMP), within one month prior to inclusion in this study. Foreseeable inability to cooperate with given instructions or study procedures.</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>nitisinone</keyword>
	<keyword>Orfadin</keyword>
	<keyword>suspension</keyword>
	<keyword>taste</keyword>
	<keyword>acceptability</keyword>
</DOC>